We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Saliva take a look at plus AI might flag chemotherapy danger, early examine outcomes recommend
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Saliva take a look at plus AI might flag chemotherapy danger, early examine outcomes recommend
Saliva take a look at plus AI might flag chemotherapy danger, early examine outcomes recommend
Health

Saliva take a look at plus AI might flag chemotherapy danger, early examine outcomes recommend

Last updated: April 21, 2025 1:50 pm
Editorial Board Published April 21, 2025
Share
SHARE

Virginia Tech researchers John Janiga, Dzenis Mahmutovic (seated), Katherine Brown, and lead investigator Carla Finkielstein work collectively within the Molecular Diagnostics Laboratory on the Fralin Biomedical Analysis Institute at VTC to develop a take a look at that would assist medical doctors establish most cancers sufferers in danger for extreme chemotherapy unintended effects. Credit score: Clayton Metz/Virginia Tech

Early outcomes from a brand new examine recommend {that a} easy saliva take a look at and highly effective synthetic intelligence algorithms might assist medical doctors establish most cancers sufferers at excessive danger for extreme unintended effects from a broadly used chemotherapy drug.

The drug, 5-fluorouracil (5-FU), has been in use because the Fifties—making it one of many oldest chemotherapy brokers nonetheless used in the present day. It stays a cornerstone of most cancers remedy, utilized in practically a 3rd of chemotherapy therapies for colorectal, breast, head and neck, pancreatic, and abdomen cancers.

5-FU disrupts how cells make and use DNA. Most cancers cells divide quickly and want to repeat their DNA constantly. The drug mimics DNA constructing blocks and jams the method, halting most cancers cell development.

However some sufferers carry genetic variations that forestall their our bodies from breaking down the drug correctly. In these instances, 5-FU can construct as much as poisonous ranges, inflicting severe and typically life-threatening issues.

About one in three folks has a diminished skill to course of 5-FU. Though the federal Meals and Drug Administration recommends screening, it’s not broadly applied.

“This isn’t just about improving outcomes, it’s about saving lives,” stated Carla Finkielstein, a professor on the Fralin Biomedical Analysis Institute at VTC and senior creator of the examine.

“For decades, 5-FU has been used with the assumption that it works the same for everyone. But we know it is not the case. Some individuals have a genetic susceptibility to this drug. Our approach adds a layer of precision to a treatment that’s been around for decades but still carries serious risks for certain patients.”

The analysis underscores the essential function of collaboration with oncologists and pathologists, whose medical insights contributed to the analysis route, Finkielstein stated.

The preliminary findings had been introduced by the main researchers of the mission, John Janiga and Dzenis Mahmutovic, on the 2025 ASCO Gastrointestinal Cancers Symposium. They had been additionally printed as an summary within the Journal of Medical Oncology, signaling early curiosity within the examine’s medical potential.

Scientists centered on mutations in a gene known as DPYD, which produces the enzyme accountable for breaking down 5-FU.

They initially analyzed DNA from wholesome volunteers and most cancers sufferers to find out whether or not saliva samples might reliably detect identified DPYD mutations. To increase past identified variants, the workforce later employed superior synthetic intelligence instruments alongside 3D protein modeling to judge 1000’s of samples.

“The AI-driven approach helped the team assess the structural and functional impact of previously unrecognized mutations in DPYD, uncovering potentially harmful variants that conventional methods might have missed,” stated Katherine Brown, the workforce’s lead bioinformatician.

A number of newly recognized DPYD mutations in colon most cancers sufferers had been predicted to impair 5-FU metabolism. Two had been labeled “pathogenic” by a number of predictive instruments and confirmed by a medical genetics database.

Some high-risk mutations had been additionally present in wholesome people, highlighting the necessity and feasibility of implementing saliva-based genetic screening for broader population-level danger evaluation, based on Finkielstein, who leads the Virginia Tech Molecular Diagnostics Laboratory on the Fralin Biomedical Analysis Institute.

“If we can flag high-risk patients early, we can tailor their treatment plans, reduce hospitalizations, and potentially avoid fatal complications,” stated Finkielstein, who can also be a professor of organic sciences within the Faculty of Science. “This is a real step forward in making cancer care safer, smarter, and more personalized.”

The early findings might increase present genetic testing and information safer, extra customized chemotherapy.

The examine was led by Finkielstein, a professor on the Fralin Biomedical Analysis Institute. Co-authors Janiga, Mahmutovic, Brown, Dulguun Myagmarsuren, and Clinton Roby are affiliated with the Molecular Diagnostics Laboratory. Douglas Grider is with the Virginia Tech Carilion Faculty of Drugs. Mark Kochenderfer is a medical oncologist with Blue Ridge Most cancers Care.

Extra info:
John M Janiga et al, Enhancing a low-cost, minimally invasive screening take a look at for dihydropyrimidine dehydrogenase mutations linked to 5-fluorouracil sensitivity by integrating computational mutation predictions, Journal of Medical Oncology (2025). DOI: 10.1200/JCO.2025.43.4_suppl.226

Supplied by
Virginia Tech

Quotation:
Saliva take a look at plus AI might flag chemotherapy danger, early examine outcomes recommend (2025, April 21)
retrieved 21 April 2025
from https://medicalxpress.com/information/2025-04-saliva-ai-flag-chemotherapy-early.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.

You Might Also Like

Combating multidrug-resistant organisms with UV mild

Blocking little-known protein might supply hope for devastating lung illness

Evaluation suggests ending grownup boosters for tetanus, diphtheria

How Trump’s Medicaid work necessities might have an effect on psychological well being care

It is by no means too early to deal with pores and skin well being, says beauty dermatologist

TAGGED:ChemotherapyEarlyflagresultsriskSalivastudysuggesttest
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Notre Dame will get late choose and subject purpose to make title recreation with 27-24 win over Penn State
Sports

Notre Dame will get late choose and subject purpose to make title recreation with 27-24 win over Penn State

Editorial Board January 10, 2025
Covid News: Omicron Hasn’t Swayed the Least Vaccinated U.S. Counties
Q&A: Do collagen, omega-3 and whey dietary supplements increase bone well being?
Cam Johnson has been a nightly unstoppable power for Nets in December
Vivian Suter’s Work Breathe With Life

You Might Also Like

Anti-nausea treatment linked to larger survival charges in ladies with triple unfavorable breast most cancers
Health

Anti-nausea treatment linked to larger survival charges in ladies with triple unfavorable breast most cancers

July 15, 2025
Micronutrient deficiency linked to persistent ache in new research
Health

Micronutrient deficiency linked to persistent ache in new research

July 15, 2025
Assist cuts, misinformation threaten youngster vaccination progress: UN
Health

Assist cuts, misinformation threaten youngster vaccination progress: UN

July 15, 2025
Vapes discovered to be simpler for smoking cessation than nicotine gum and lozenges
Health

Vapes discovered to be simpler for smoking cessation than nicotine gum and lozenges

July 15, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?